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Abstract
The bacterial reverse mutation test, commonly called Ames test, is used worldwide. In Japan, the genetically
modified organisms (GMOs) are regulated under the Cartagena Domestic Law, and organisms obtained by self-
cloning and/or natural occurrence would be exempted from the law case by case. The strains of Salmonella
typhimurium and Escherichia coli recommended for use in the bacterial reverse mutation test (OECD guideline 471),
have been considered as non-GMOs because they can be constructed by self-cloning or naturally occurring
bacterial strains, or do not disturb the biological diversity. The present article explains the reasons why these tester
strains should be classified as non-GMOs.
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Definition of genetically modified organisms
Genetically modified organisms (GMOs) are defined as
an organism “in which the genetic material (DNA) has
been altered in a way that does not occur naturally by
mating and/or natural recombination, without using
modern recombinant DNA technology” [1]. Accordingly,
organisms are considered to be a non-GMO if they are
made by the transfer of genetic material through bacter-
ial conjugation between same/different species. For ex-
ample, the transfer of the antibiotic resistance genes
naturally occurs by bacterial conjugation in a broad host
range [2]. It is also known that bacteria gain the property
of antibiotic resistance through the genetic mutations
and horizontal transfer of the antibiotic resistance genes
under selective pressures [3]. Therefore, non-GMOs are
not considered to disturb the biological diversity.
Gene mutations of the Ames tester strains recommended
in OECD guideline 471
The strains which are used in the bacterial reverse
mutation test (OECD guideline 471) [4] are derivatives
of S. enterica serovar Typhimurium (S. typhimurium)
LT2 or E. coli B strain [5–7]. All the Ames tester strains
recommended for use in the bacterial reverse mutation
test are listed in Table 1. The Salmonella tester strains
harbor different mutations (hisD3052, hisG46, hisC3076,
hisG428, hisD6610 and hisO1242) in the genes of the
histidine operon of S. typhimurium. The Salmonella
strains originated from S. typhimurium LT2 are histidine
auxotrophs which are the result from treatment with
mutagens or radiation [5, 6, 8–13]. In addition, the all
Salmonella tester strains carry an rfa (deep rough) mu-
tation for permeation of test chemicals, and the strains
except for TA102 have a deletion mutation of uvrB gene
to keep adducts generated with test chemicals as well as
gal, chl, and bio genes [5, 6, 14]. The two tester strains
of E. coli carry a terminating ochre mutation in the trpE
gene as well as a uvrA mutation [15, 16]. Thus, the
genetic background changes (mutations) in the Ames
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tester strains can naturally occur without using modern
recombinant DNA technology.
pKM101 plasmid can naturally occur and self-
transmissible
As shown in Table 1, the five strains of S. typhimurium
(TA98, TA100, TA102, TA97 and TA97a) and one strain
of E. coli (WP2uvrA/pKM101) harbor plasmid pKM101.
Plasmid pKM101 carries an ampicillin resistance gene
and mucAB genes encoding analogs of UmuD/C pro-
teins of E. coli, which are involved in error-prone DNA
repair [6, 17]. pKM101 (35.4 kb) is derived from its clin-
ically isolated parent R46 plasmid by an in vivo 14-kb
deletion [18]. R46 plasmid contains four drug-resistance
genes, while pKM101 dose not contain the other three
drug-resistance genes with the exception of the ampicil-
lin resistance gene [19, 20]. In addition, since R plasmids
have a self-transmissible nature, pKM101 is normally
present in the members of the family Enterobacteriaceae
including the genera Salmonella and Escherichia [6, 17].
Taken together, plasmid pKM101 is considered to be a
derivative of a naturally occurring plasmid, and self-
transmittable.
pAQ1 plasmid in the Ames tester strains does not disturb
the biological diversity
The S. typhimurium TA102 strain harbors plasmids
pAQ1 in addition to pKM101. The pAQ1 is a derivative
of pBR322 and carries the target DNA sequence for re-
version, hisG428, a part of the histidine biosynthetic op-
eron originated from S. typhimurium. Thus, hisG428 is a
self-cloned gene. The vector pBR322 consists of the fol-
lowing DNA segments assembled in vitro; the tetracyc-
line resistance gene, ampicillin resistance gene, and the
replicator regions derived from colicin plasmid, pMB1
[21, 22]. The two drug resistance genes are derived from
transposons, Tn10 and Tn3, respectively [22, 23]. Trans-
posons are known to be transferred between related bac-
teria [24]. So, the drug resistance genes can be naturally
introduced into the genome of S. typhimurium. The
hisG428 gene is inserted into the ampicillin resistance
gene. It was also reported that S. typhimurium LT2
strains are inherently non-colicinogenic, but the strain
was shown to have an ability to receive colicin plasmids
from E. coli through conjugation [17, 25, 26]. Thus S.
typhimurium has a possibility to have the plasmid pMB1
as well as toxin colicin naturally in their cells even with-
out introducing pAQ1. Therefore, the introduction of
pAQ1 into the Ames tester strains does not disturb the
biological diversity of S. typhimurium, and pAQ1 plas-
mid can be generated via self-cloning technology and
transferred to S. typhimurium LT2.
Conclusion
In Japan, the Cartagena Domestic Law regulates living
organisms resulting from modern biotechnology in-
cluding recombinant DNA technology, and probable
exemptions for microorganisms obtained by self-
cloning and/or “natural occurrence” are assessed and
decided case by case (for each produced organism)
[27, 28]. Based on the following stated reasons, we
conclude that all the Ames tester strains recommended
for use in the bacterial mutation test [4] can be certi-
fied as non-GMOs;
1) Genetic backgrounds of the nine strains
recommended for use in the bacterial mutation test
[4] can be generated spontaneously, or by radiation
or chemicals.
2) pKM101 harbored in the tester strains TA97, TA97a,
TA98, TA100, TA102, and WP2uvrA/pKM101 is a
naturally occurring plasmid and self-transmittable.
3) pAQ1 plasmid which the strain TA102 carries, can
be generated via self-cloning technology and trans-
ferred to S. typhimurium LT2 by conjugation.
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Table 1 Strains recommended for use in the bacterial reverse mutation test (OECD guideline 471)
Strain Orignal Genotype Plasmid
S. typhimurium TA98 S. typhimurium LT2 hisD3052 rfa Δ(gal chl bio uvrB) pKM101
S. typhimurium TA100 S. typhimurium LT2 hisG46 rfa Δ(gal chl bio uvrB) pKM101
S. typhimurium TA1535 S. typhimurium LT2 hisG46 rfa Δ(gal chl bio uvrB) None
S. typhimurium TA1537 S. typhimurium LT2 hisC3076 rfa Δ(gal chl bio uvrB) None
S. typhimurium TA102 S. typhimurium LT2 hisG428 rfa galE hisΔ(G)8476 pKM101, pAQ1
S. typhimurium TA97/TA97a S. typhimurium LT2 hisD6610 hisO1242 rfa Δ(gal chl bio uvrB) pKM101
E. coli WP2uvrA E. coli B trpE uvrA None
E. coli WP2uvrA/pKM101 E. coli B trpE uvrA pKM101
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